It's a good thing. I also think they need to pivot back to a narrower focus on goat formula IMO. But whether the product is good or bad is kind of irrelevant if they have not figured out a China distribution strategy that doesn't hinge on daigou.
Ann: Bubs Q3 FY24 Quarterly Activity and Cashflow Statement, page-83
Add BUB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
-0.005(3.57%) |
Mkt cap ! $120.5M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 14.5¢ | 13.5¢ | $411.0K | 2.895M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 734640 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 68549 | 4 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| BUB (ASX) Chart |